{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:01:37Z","timestamp":1761166897627,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jocd.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T20:01:19Z","timestamp":1346875279000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of Serum Dkk1 (Dickkopf-1) and Bone Mineral Density in Patients on Bisphosphonate Treatment Vs no Treatment"],"prefix":"10.1016","volume":"16","author":[{"given":"Adeel R.","family":"Memon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael V.","family":"O'Riordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borislav D.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Harty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jocd.2012.07.003_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jocd.2012.07.003_bib2","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.jocd.2012.07.003_bib3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00198-004-1627-0","article-title":"An estimate of the worldwide prevalence, mortality and disability associated with hip fracture","volume":"15","author":"Johnell","year":"2004","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.jocd.2012.07.003_bib4","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/archinte.1989.00390110045010","article-title":"Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women","volume":"149","author":"Cummings","year":"1989","journal-title":"Arch Intern Med"},{"issue":"9319","key":"10.1016\/j.jocd.2012.07.003_bib5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"issue":"5573","key":"10.1016\/j.jocd.2012.07.003_bib6","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1126\/science.1071549","article-title":"The promise and perils of Wnt signaling through beta-catenin","volume":"296","author":"Moon","year":"2002","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jocd.2012.07.003_bib7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/bies.10164","article-title":"Increasingly complex: new players enter the Wnt signaling network","volume":"24","author":"Pandur","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.jocd.2012.07.003_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","article-title":"The Wnt signaling pathway in development and disease","volume":"20","author":"Logan","year":"2004","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.jocd.2012.07.003_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-3-1-reviews3001","article-title":"The Wnts","volume":"3","author":"Miller","year":"2002","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.jocd.2012.07.003_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/beta-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jocd.2012.07.003_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"issue":"2","key":"10.1016\/j.jocd.2012.07.003_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0378-1119(99)00365-0","article-title":"Functional and structural diversity of the human Dickkopf gene family","volume":"238","author":"Krupnik","year":"1999","journal-title":"Gene"},{"issue":"31","key":"10.1016\/j.jocd.2012.07.003_bib13","doi-asserted-by":"crossref","first-page":"21427","DOI":"10.1074\/jbc.M800014200","article-title":"DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation","volume":"283","author":"Semenov","year":"2008","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1016\/j.jocd.2012.07.003_bib14","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/MCB.00222-08","article-title":"Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density","volume":"28","author":"Ellwanger","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"6889","key":"10.1016\/j.jocd.2012.07.003_bib15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature756","article-title":"Kremen proteins are Dickkopf receptors that regulate Wnt\/beta-catenin signalling","volume":"417","author":"Mao","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jocd.2012.07.003_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jocd.2012.07.003_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.jocd.2012.07.003_bib18","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1074\/jbc.M412817200","article-title":"Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation","volume":"280","author":"Plotkin","year":"2005","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.jocd.2012.07.003_bib19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.jocd.2012.07.003_bib20","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1359\/jbmr.2002.17.11.1988","article-title":"Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis","volume":"17","author":"Rizzoli","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jocd.2012.07.003_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00003088-200544060-00001","article-title":"Pharmacokinetics\/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis","volume":"44","author":"Cremers","year":"2005","journal-title":"Clin Pharmacokinet"},{"unstructured":"Patient safety information about radiation risks. Available at: www.radiologyinfo.org. Accessed July 30, 2012.","key":"10.1016\/j.jocd.2012.07.003_bib22"},{"issue":"9","key":"10.1016\/j.jocd.2012.07.003_bib23","first-page":"3109","article-title":"Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group","volume":"85","author":"Tonino","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jocd.2012.07.003_bib24","first-page":"1492","article-title":"Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group","volume":"85","author":"Ravn","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jocd.2012.07.003_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3324\/haematol.2008.000893","article-title":"Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration","volume":"94","author":"Voskaridou","year":"2009","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.jocd.2012.07.003_bib26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1055\/s-0029-1233491","article-title":"The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone","volume":"41","author":"Polyzos","year":"2009","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.jocd.2012.07.003_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jocd.2010.01.006","article-title":"Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1","volume":"13","author":"Polyzos","year":"2010","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1016\/j.jocd.2012.07.003_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11357-008-9069-9","article-title":"Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation","volume":"30","author":"Rauner","year":"2008","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.jocd.2012.07.003_bib29","first-page":"11","article-title":"The role of Dkk1 in bone mass regulation: correlating serum Dkk1 expression with bone mineral density","volume":"11","author":"Butler","year":"2010","journal-title":"J Orthop Res"},{"issue":"4","key":"10.1016\/j.jocd.2012.07.003_bib30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"issue":"34","key":"10.1016\/j.jocd.2012.07.003_bib31","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1016\/j.biomaterials.2005.04.059","article-title":"Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells","volume":"26","author":"von Knoch","year":"2005","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jocd.2012.07.003_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2008-01-132134","article-title":"Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma","volume":"112","author":"Qiang","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jocd.2012.07.003_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:38:10Z","timestamp":1761082690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695012001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1094695012001059"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2012.07.003","relation":{},"ISSN":["1094-6950"],"issn-type":[{"type":"print","value":"1094-6950"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Serum Dkk1 (Dickkopf-1) and Bone Mineral Density in Patients on Bisphosphonate Treatment Vs no Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2012.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}